Clinical Endocrinology

Cover image for Vol. 77 Issue 1

July 2012

Volume 77, Issue 1

Pages 1–157

  1. Review Article

    1. Top of page
    2. Review Article
    3. Commentary
    4. Clinical Question
    5. Original Articles
    6. Letters to the Editor
    1. You have free access to this content
      Genetic aspects of adrenocortical tumours and hyperplasias (pages 1–10)

      Tânia L. Mazzuco, Julien Durand, Audrey Chapman, Jefferson Crespigio and Isabelle Bourdeau

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2012.04403.x

      • image
      • image
  2. Commentary

    1. Top of page
    2. Review Article
    3. Commentary
    4. Clinical Question
    5. Original Articles
    6. Letters to the Editor
  3. Clinical Question

    1. Top of page
    2. Review Article
    3. Commentary
    4. Clinical Question
    5. Original Articles
    6. Letters to the Editor
    1. What are the keys to successful thyroid FNA interpretation? (pages 13–17)

      Thomas J. Sebo

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2012.04404.x

      • image
  4. Original Articles

    1. Top of page
    2. Review Article
    3. Commentary
    4. Clinical Question
    5. Original Articles
    6. Letters to the Editor
    1. Adrenal

      A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency (pages 18–25)

      Bertil Ekman, Margareta Bachrach-Lindström, Torbjörn Lindström, Jeanette Wahlberg, Johan Blomgren and Hans J. Arnqvist

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2012.04352.x

      • image
      • image
      • image
      • image
    2. Bone/Calcium

      Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study (pages 26–35)

      Robin M. Daly, Claudia Gagnon, Zhong X. Lu, Dianna J. Magliano, David W. Dunstan, Ken A. Sikaris, Paul Z. Zimmet, Peter R. Ebeling and Jonathan E. Shaw

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04320.x

      • image
      • image
      • image
    3. Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins (pages 36–41)

      Daniel Kurnik, Israel Hochman, Janet Vesterman-Landes, Tali Kenig, Itzhak Katzir, Yosef Lomnicky, Hillel Halkin and Ronen Loebstein

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04321.x

      • image
      • image
    4. Diabetes/Lipids/Obesity/Metabolism

      A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort (pages 42–46)

      Chardpraorn Ngarmukos, La-or Chailurkit, Suwanee Chanprasertyothin, Bunlue Hengprasith, Piyamitr Sritara and Boonsong Ongphiphadhanakul

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04215.x

      • image
      • image
    5. Chemerin levels are positively correlated with abdominal visceral fat accumulation (pages 47–50)

      Hyun-Young Shin, Duk C. Lee, Sang H. Chu, Justin Y. Jeon, Mi K. Lee, Jee A. Im and Ji W. Lee

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04217.x

      • image
    6. Diabetic peripheral neuropathy is highly associated with nontraumatic fractures in Korean patients with type 2 diabetes mellitus (pages 51–55)

      Ji-Hyun Kim, Mi-Hyang Jung, Jung-Min Lee, Hyun-Shik Son, Bong-Yun Cha and Sang-Ah Chang

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04222.x

    7. Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients (pages 56–61)

      David J. Friedman, Nisha Bhatt, Najwah S. Hayman, Brendan J. Nichols, Mark Herman, Nikolay Nikolaev and John Danziger

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04229.x

      • image
      • image
      • image
      • image
    8. Paediatric Endocrinology

      You have free access to this content
      Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature (pages 62–71)

      Ian P. Hughes, Mark Harris, Catherine S. Choong, Geoff Ambler, Wayne Cutfield, Paul Hofman, Chris T. Cowell, George Werther, Andrew Cotterill, Peter S. W. Davies and on behalf of the Australasian Paediatric Endocrine Group (APEG)

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04230.x

      • image
      • image
      • image
      • image
    9. Pituitary/Neuroendocrinology

      Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly (pages 72–78)

      Ansgar Heck, Geir Ringstad, Stine L. Fougner, Olivera Casar-Borota, Terje Nome, Jon Ramm-Pettersen and Jens Bollerslev

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04286.x

      • image
    10. Adolescent acromegaly and decreased arterial distensibility despite successful treatment (pages 79–85)

      Pier P. Bassareo, Andrea R. Marras and Giuseppe Mercuro

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04325.x

    11. Effects of recombinant human growth hormone therapy in adults with Prader–Willi syndrome: a meta-analysis (pages 86–93)

      Ruth Sanchez-Ortiga, Anne Klibanski and Nicholas A. Tritos

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04303.x

      • image
    12. Glucocorticoid replacement therapy and fibrinolysis in patients with hypopituitarism (pages 94–98)

      Steven R. Peacey, Dianne Wright, Mo Aye and Robert Moisey

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04314.x

      • image
    13. Changes in heart valve structure and function in patients treated with dopamine agonists for prolactinomas, a 2-year follow-up study (pages 99–105)

      Victoria Delgado, Nienke R. Biermasz, Sjoerd W. van Thiel, See H. Ewe, Nina Ajmone Marsan, Eduard R. Holman, Richard A. Feelders, Johannes W. A. Smit, Jeroen J. Bax and Alberto M. Pereira

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04326.x

      • image
    14. Reproduction

      Association between plasma 25-OH vitamin D and testosterone levels in men (pages 106–112)

      Katharina Nimptsch, Elizabeth A. Platz, Walter C. Willett and Edward Giovannucci

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2012.04332.x

      • image
      • image
    15. The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population (pages 113–119)

      A. Capalbo, F. Sagnella, R. Apa, A. M. Fulghesu, A. Lanzone, A. Morciano, A. Farcomeni, M. F. Gangale, F. Moro, D. Martinez, A. Ciardulli, C. Palla, M. L. Uras, F. Spettu, A. Cappai, C. Carcassi, G. Neri and F. D. Tiziano

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2012.04372.x

    16. Impact of the FTO gene variation on fat oxidation and its potential influence on body weight in women with polycystic ovary syndrome (pages 120–125)

      Irina Kowalska, Agnieszka Adamska, Maciej T. Malecki, Monika Karczewska-Kupczewska, Agnieszka Nikolajuk, Magdalena Szopa, Maria Gorska and Marek Straczkowski

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2012.04379.x

      • image
    17. Thyroid

      Lateral cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the lateral compartment (pages 126–131)

      Mubashir G. Mulla, Wolfram Trudo Knoefel, Jackie Gilbert, Alan McGregor and Klaus-Martin Schulte

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2012.04336.x

    18. Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy (pages 132–138)

      Fernanda Vaisman, Denise Momesso, Daniel A. Bulzico, Cencita H. C. N. Pessoa, Fernando Dias, Rossana Corbo, Mário Vaisman and R. Michael Tuttle

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2012.04342.x

      • image
    19. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas (pages 139–145)

      Karsten Müssig, Tobias Wehrmann, Helmut Dittmann, Manfred Wehrmann, Bianca Ueberberg, Stefan Schulz, Roland Bares and Stephan Petersenn

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2012.04343.x

      • image
      • image
    20. Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism (pages 146–151)

      G. Das, T. A. Ojewuyi, P. Baglioni, J. Geen, L. D. Premawardhana and O. E. Okosieme

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2012.04345.x

      • image
  5. Letters to the Editor

    1. Top of page
    2. Review Article
    3. Commentary
    4. Clinical Question
    5. Original Articles
    6. Letters to the Editor
    1. Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma (pages 154–155)

      Maralyn Druce, Teng-Teng Chung, Simona Grozinsky-Glasberg, David J. Gross and Ashley B. Grossman

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04296.x

    2. Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm? (pages 155–157)

      Julia R Murray, Graham R Williams, Kevin J Harrington, Kate Newbold and Chris M Nutting

      Version of Record online: 6 JUN 2012 | DOI: 10.1111/j.1365-2265.2011.04310.x

      • image

SEARCH

SEARCH BY CITATION